German Medical Devices Act
This article was originally published in The Gray Sheet
Second amendment expanding surveillance of device reprocessing will go into effect in January, following passage by the German parliament. The law requires standard conformity assessment of reprocessed devices if the products are not returned by the third party to the original user. Additionally, external reprocessors will be incorporated into CA surveillance systems and be obligated to register any reprocessed devices. Advertising regulations will be modified under the amendment, which also addresses Internet advertising and the creation of a patient-oriented information policy...
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.